Zepbound

Healthcare

Weight-Loss Giants Have Investors Back on Their Side

Photo by Chemist4U via CC BY-SA 2.0

It can be hard to sate investors’ appetites, but if there’s two companies who should know how to do it, it’s these two.

1 min read

Photo by Coolcaesar via CC BY-SA 4.0

Healthcare

Merck Cautiously Enters GLP-1 Fray Via Licensing Deal With Chinese Drugmaker

By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals’ dominance in the GLP-1 space.

2 min read
Photo by Jetcityimage via iStock

Healthcare

Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List

The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.

1 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Making Weight-Loss Drugs Takes a Whole Lot of Muscle

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

1 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.